Thrombus Analysis of Ischemic Stroke

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSeoul National University Hospital

About this trial

Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with acute ischemic stroke who had undergone endovascular thrombectomy

Disqualifiers

None

Trial population

patients with acute ischemic stroke who had undergone endovascular thrombectomy and agreed to participate to the study

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • thrombus analysis

    Diagnostic test

    Detailed expression pattern of RNA and histological characteristics will be investigated.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Vascular events

major vascular events after endovascular thrombectomy, including stroke, myocardial infarction, and vascular death

Time frame
two years after initial stroke

Secondary outcomes

1

Thromboembolic events

Any thromboembolic events after endovascular thrombectomy including ischemic stroke, transient ischemic attack, myocardial infarction or unstable angina, peripheral artery disease requiring hospitalization, venous thromboembolism, pulmonary embolism and vascular death

Time frame
two years after initial stroke

Other outcomes

1

overall mortality

any death event after endovascular thrombectomy

Time frame
two years after initial stroke

Sponsors and contacts

Click on the lead sponsor to view all of their trials.